Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Masterson

Showing results (31-40 of 112) with videos related to

Pageof 12
Sort By:
The Journal of Urology|February 23, 2010
How do you tell whether a change in surgical technique leads to a change in outcome?Andrew J Vickers, Angel M Cronin, Timothy A Masterson, et al.
Urology|September 6, 2005
Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapyTimothy A Masterson, Andrew J Stephenson, Peter T Scardino, et al.
Urology|April 14, 2009
Nerve-sparing prostatectomy and urinary function: a prospective analysis using validated quality-of-life measuresE Jason Abel, Timothy A Masterson, Jonathan N Warner, et al.
The Journal of Urology|March 25, 2025
Reply by AuthorsJiping Zeng, Jacob McFadden, Parth Thakker, et al.
The Journal of Urology|February 20, 2025
Retroperitoneal Nodal Distribution for Metastatic Seminoma: Is Modified Template Appropriate? A Retrospective StudyJiping Zeng, Jacob McFadden, Parth Thakker, et al.
European Urology|April 5, 2026
Diagnostic Accuracy of Circulating Tumor DNA to Predict Retroperitoneal Histology in Patients Treated With Retroperitoneal Lymph Node Dissection for Testicular Germ TumorParth U Thakker, Connor Drake, Jiping Zeng, et al.
Urologic Oncology|February 14, 2026
Clinical stage IIA/B embryonal carcinoma predominant nonseminomatous germ cell tumor: Minimizing treatment burdenJiping Zeng, Parth Thakker, Timothy A Masterson, et al.
Urology|September 14, 2025
Histologic Concordance Between Post-chemotherapy RPLND and Orchiectomy When Performed Simultaneously: Insights Into the Blood-Testis BarrierParth U Thakker, Jiping Zeng, Connor Drake, et al.
European Urology|August 25, 2019
Reply to Gregory J. Nason, Michael A.S. Jewett, and Robert J. Hamilton's Letter to the Editor re: Adam C. Calaway, Lawrence H. Einhorn, Timothy A. Masterson, Richard S. Foster, Clint Cary. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer. Eur Urol 2019;76:607-609: Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular CancerAdam C Calaway, Lawrence H Einhorn, Timothy A Masterson, et al.
European Urology|June 9, 2019
Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular CancerAdam C Calaway, Lawrence H Einhorn, Timothy A Masterson, et al.
Pageof 12

Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
The Journal of Urology|February 23, 2010
How do you tell whether a change in surgical technique leads to a change in outcome?Andrew J Vickers, Angel M Cronin, Timothy A Masterson, et al.
Urology|September 6, 2005
Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapyTimothy A Masterson, Andrew J Stephenson, Peter T Scardino, et al.
Urology|April 14, 2009
Nerve-sparing prostatectomy and urinary function: a prospective analysis using validated quality-of-life measuresE Jason Abel, Timothy A Masterson, Jonathan N Warner, et al.
The Journal of Urology|March 25, 2025
Reply by AuthorsJiping Zeng, Jacob McFadden, Parth Thakker, et al.
The Journal of Urology|February 20, 2025
Retroperitoneal Nodal Distribution for Metastatic Seminoma: Is Modified Template Appropriate? A Retrospective StudyJiping Zeng, Jacob McFadden, Parth Thakker, et al.
European Urology|April 5, 2026
Diagnostic Accuracy of Circulating Tumor DNA to Predict Retroperitoneal Histology in Patients Treated With Retroperitoneal Lymph Node Dissection for Testicular Germ TumorParth U Thakker, Connor Drake, Jiping Zeng, et al.
Urologic Oncology|February 14, 2026
Clinical stage IIA/B embryonal carcinoma predominant nonseminomatous germ cell tumor: Minimizing treatment burdenJiping Zeng, Parth Thakker, Timothy A Masterson, et al.
Urology|September 14, 2025
Histologic Concordance Between Post-chemotherapy RPLND and Orchiectomy When Performed Simultaneously: Insights Into the Blood-Testis BarrierParth U Thakker, Jiping Zeng, Connor Drake, et al.
European Urology|August 25, 2019
Reply to Gregory J. Nason, Michael A.S. Jewett, and Robert J. Hamilton's Letter to the Editor re: Adam C. Calaway, Lawrence H. Einhorn, Timothy A. Masterson, Richard S. Foster, Clint Cary. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer. Eur Urol 2019;76:607-609: Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular CancerAdam C Calaway, Lawrence H Einhorn, Timothy A Masterson, et al.
European Urology|June 9, 2019
Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular CancerAdam C Calaway, Lawrence H Einhorn, Timothy A Masterson, et al.
Pageof 12